STAT3 and pulmonary arterial hypertension: Similar results have not been reported in PAECs, and the current study enriches the cellular mechanisms of Drp1-mediating mitochondrial fission in pulmonary remodeling and provides more evidence for the feasibility of targeting STAT3 or Drp1-mediate mitochondrial fission as a therapeutic option for PAH.